(19)
(11) EP 1 603 897 A1

(12)

(43) Date of publication:
14.12.2005 Bulletin 2005/50

(21) Application number: 04720088.6

(22) Date of filing: 12.03.2004
(51) International Patent Classification (IPC)7C07D 401/12, C07D 405/14, C07D 401/14, C07D 409/14, C07D 409/12, C07D 413/12, C07D 231/14, A61K 31/4155, A61P 29/00
(86) International application number:
PCT/GB2004/001054
(87) International publication number:
WO 2004/080999 (23.09.2004 Gazette 2004/39)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 14.03.2003 SE 0300705
26.06.2003 US 482563 P

(71) Applicant: Biolipox AB
102 34 Stockholm (SE)

(72) Inventors:
  • HALLBERG, Anders,Uppsala Univ.,Biomedical Centre
    S-751 23 Uppsala (SE)
  • SCHAAL, Wesley,Biolipox AB
    S-102 34Stockholm (SE)
  • LARHED, Mats,Uppsala Univ.,Biomedical Centre
    S-751 23 Uppsala (SE)
  • OLOFSSON, Kristofer,Biolipox AB
    S-102 34 Stockholm (SE)
  • PELCMAN, Benjamin,Biolipox AB
    S-10234 Stockholm (SE)
  • SANIN, Andrei,Biolipox AB
    S-102 34 Stockholm (SE)

(74) Representative: McNeeney, Stephen Phillip 
Eric Potter Clarkson, Park View House, 58 The Ropewalk
Nottingham NG1 5DD
Nottingham NG1 5DD (GB)

   


(54) PYRAZOLE COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION